China Developed the World's 1st Super AI Hospital
An English translation and commentary of the full text is provided within the substack
Member’s Commentary
Guo Jianguang’s (郭建光) commentary:
The article captures a pivotal moment in China’s healthcare digitization strategy: the simultaneous release of the first international consensus on AI hospitals and the physical launch of the world’s first “super AI hospital” in Hainan. The Super AI Hospital, formally named Hainan Boao Super Digital Intelligence Hospital Management Co, is a joint venture between state owned and private entities.
The technology platform at the center of this hospital, called the Smart Consortium MaaS Platform, is a “Model as a Service” architecture integrating three engines: a medical knowledge graph, evidence-based medicine databases, and real-world clinical data. Its “thousand-disease agents” and “thousand-hospital agents” modules are designed to monitor global pharmaceutical developments, identify matching patients, and coordinate treatment pathways across institutions.
AI transforms healthcare from a reactive service into a coordinated, anticipatory system, improving efficiency and reducing patient anxiety. Traditionally, healthcare delivery has been constrained by: uneven spatial distribution of resources, fragmented institutional coordination and high transaction costs for patients. The Super AI hospital addresses all 3 through: centralized coordination and allocation, distributed execution capacity and continuous service provision.
The shift to proactive health management reduces long-term systemic costs, improves population health outcomes and enhances the state’s capacity to manage public health risks. Its service twinning, otherwise known as digital twinning creates a parallel digital dynamic co-evolving system of the operational floor. It operates in a unified informational environment, where previously fragmented information (patient histories, treatment outcomes, pharmaceutical inventories) are integrated in one computational network.
Which allows it to actively anticipate demand, simulate intervention methods and optimize decision making before physical steps are taken. Instead of a doctor looking up information on an ad hoc basis, the parallel digital system identifies needs, matches treatments, and initiates workflows before the human actors participate. It can: forecasts patient needs based on real-time and longitudinal data, matches those needs with available drugs, devices, and expertise and coordinate across institutions to allocate resources efficiently.
In practical terms, service twinning increases efficiency by eliminating the fragmented, trial-and-error pathway a patient normally experiences. For example, instead of a patient visiting multiple hospitals, waiting for referrals, and manually searching for suitable drugs or specialists, the digital twin continuously analyzes their medical data, matches it against global treatment options, and preselects the optimal care pathway before the patient even arrives.
Appointments, diagnostics, drug availability, and follow-up care are coordinated in advance across institutions, reducing redundant visits, wait times, and misallocation of resources. The result is that what once required weeks of sequential decision-making and physical movement is compressed into a streamlined, largely preorchestrated process executed with minimal delay.
If the Lecheng model proves effective, expect to see similar AI-driven medical hospitals proposed for other special economic zones in China. The Lecheng model effectively constructs a nationally scalable service network that reduces inefficiencies and equalizes access to medication.
World’s First Super AI Hospital Opens in Hainan (全球首家超级AI医院落地海南 智慧医联体赋能健康新生态)
Source: Baidu Baijiahao | Author: China.org中国网 | Date: March 26, 2026
Author Background: This article was originally published by China.org , a state media portal under the State Council Information Office, as part of its coverage of the 2026 Zhongguancun World Digital Health Forum.
Brief outline
1. The first international consensus defining “AI hospitals” was released at the 2026 Zhongguancun World Digital Health Forum in Beijing.
2. The world’s first “Super AI Hospital” was launched the same day in Hainan’s Boao Lecheng pilot zone.
3. The hospital uses a three-stage model: local diagnosis, centralized treatment in Lecheng, and follow-up care in the patient’s home region.
4. Lecheng’s unique regulatory privileges, including access to imported drugs and devices not yet approved in mainland China, give the hospital a privileged operating environment.
5. The MaaS platform integrates AI agents for disease matching, pharmaceutical tracking, and cross-institutional coordination.
Note: All messages in bold-italics are highlighted for emphasis by the translators, and were not bold-italicized in the original transcript. The illustration was generated by Gemini’s Nano Banana 2.
On March 26, at the 2026 Zhongguancun World Digital Health Forum held in Beijing, leading medical and AI experts from China and abroad jointly released the International AI Hospital Smart Consortium Consensus, the first consensus-based definition of AI hospitals at the international level.
At the same time, Hainan’s Boao Lecheng International Medical Tourism Pilot Zone (博鳌乐城国际医疗旅游先行区) gained a landmark project: the world’s first super AI hospital officially opened.
Experts noted that the launch of the super AI hospital closely echoes this international consensus, with real clinical services as the foundation and artificial intelligence as the restructuring engine, signaling that AI hospitals are accelerating from academic consensus toward industrial practice.
The Boao Lecheng International Medical Tourism Pilot Zone gained a landmark project on March 26: the world’s first super AI hospital officially opened.
This new type of hospital, driven by AI across the entire medical process, will leverage the pilot zone’s special policy advantages and its concentration of global medical resources to explore a new model of smart healthcare integrating online and offline services.
Industry experts describe the super AI hospital’s distinguishing feature in a single phrase: “online AI platform + offline medical consortium + full-cycle management.” The hospital uses an AI-native philosophy to reconstruct the medical service system from the ground up, deeply integrating the specialist depth of offline medical care with the broad accessibility of online services. The goal is full-time, all-domain, all-dimensional, and whole-process proactive health care, turning the hospital into a continuously evolving intelligent organism.
At the 2026 Zhongguancun World Digital Health Forum, top medical and AI experts from China and abroad jointly released the International AI Hospital Smart Consortium Consensus. For the first time, the international community reached a consensus-based definition of AI hospitals. The consensus states that an AI hospital is a new paradigm of smart health driven by “service twinning (服务孪生),” using AI-native thinking to reconstruct the medical service system from the ground up. It deeply integrates the specialist depth of offline care with the broad reach of online services, achieving virtual-real symbiosis and coordinated connectivity to deliver proactive health care across all times, domains, dimensions, and processes, making the hospital a continuously evolving intelligent organism.
Experts indicated that the super AI hospital’s launch forms a tight echo with this international consensus, built on real medical services as a foundation with artificial intelligence as the restructuring engine. This marks AI hospitals accelerating from academic consensus toward industrial practice.
The super AI hospital’s full name is Hainan Boao Super Digital Intelligence Hospital Management Co. (海南博鳌超级数智医院管理有限公司), located in the core area of the “Never-Ending” International Innovation Drug and Device Exhibition within the Lecheng pilot zone. The project was jointly funded by Qionghai Municipal State-Owned Asset Operating Co., Beijing Qingyi Huabao Health Technology Co. (清医华保), and Yueergwan (Qingdao) Internet Hospital Co. (悦尔湾), with core technology support from Xiamen Yueergwan Health Technology Investment Co.
“In the past, patients who wanted access to the latest global pharmaceutical products might have to visit multiple hospitals and wait months. Now, AI helps you find them, match them, and track them,” said Zhang Bangqun (张邦群), the super AI hospital’s general manager. He explained that the hospital has built an AI Hospital Smart Consortium system and a MaaS (Model as a Service) achievement promotion platform, connecting the entire chain from technology research and development to clinical application. “Before, patients went around the world looking for drugs. Now, the right drugs find the right people.”
Powered by the “thousand-disease intelligent agents” and “thousand-hospital intelligent agents” core modules embedded in the platform, along with an AI assistant, the super AI hospital can monitor global pharmaceutical and device developments around the clock, proactively identifying patients matching specific indications through intelligent assessment and precisely matching treatment plans. Meanwhile, the Yueergwan app connects medical AI technology providers with users, accelerating the deployment of high-quality medical AI technology and bringing it out of the laboratory so patients can avoid unnecessary trips.
In terms of service delivery, the super AI hospital has partnered with hospitals across the country to form a medical consortium, implementing a three-stage collaborative mechanism: “local diagnosis, treatment in Lecheng, follow-up back home.” The core objective is straightforward: patients travel less, resources flow more.
Experts told reporters that after a patient leaves the hospital, a multimodal full-cycle health management system continues to track and serve them, comprehensively covering health needs across the entire life cycle. This pushes medical services from passive diagnosis and treatment toward proactive health management. This “online AI platform + offline medical consortium + full-cycle management” model already has a replicable and scalable basic framework.
Industry experts said that the super AI hospital’s launch fills a gap in China’s practical experience with service-twin-driven AI hospitals, and also provides an observable real-world sample for the standardized and large-scale application of AI in medicine. With the international academic community having just reached a consensus on the definition and pathway of AI hospitals, this practical exploration in Boao carries particular significance as a benchmark.
“Super Soil” Breeds a “Super Hospital”
The decision to locate the super AI hospital in Lecheng has deep logic behind it. The Lecheng International Medical Tourism Pilot Zone was established in February 2013 with State Council approval, to pilot the development of specialized healthcare including特许医疗, oncology treatment, health management, rehabilitation care, and anti-aging medicine. Its goal is to achieve “three synchronizations” with international advanced levels in medical technology, equipment, and pharmaceuticals. It is the only medical sector special economic zone in China open to foreign investment.
According to the Lecheng Pilot Zone Administration’s official account, on March 20, Zhou Changqiang (周长强), Party Secretary of Qionghai City and Party Secretary of the Lecheng Administration, stated at the unveiling ceremony of a medical exchange center that Lecheng is accelerating the gathering of high-end medical resources and promoting international medical cooperation to a higher level, so that more quality medical resources and innovative achievements can better serve patients worldwide.
The same account reported on March 25 that the International Innovation Pharmaceutical and Device Product Lecheng Matchmaking Event was held in the pilot zone that day, attracting participation from 36 domestic and international pharmaceutical companies including Boston Scientific, GE Healthcare, Medtronic, MSD, and Eisai, along with 29 medical institutions and specialists from relevant committees. Officials from the Hainan Provincial Drug Administration and Health Commission stated they would continue to deepen approval service reform, strengthen Lecheng’s policy advantages, and facilitate connections between medical institutions and enterprises to promote deeper integration of research and production, allowing innovative drugs and devices to benefit patients more quickly.
Data published by the Lecheng Pilot Zone Administration shows that as of January this year, 553 licensed products, had been approved for entry through Lecheng, including 187 drugs, 353 medical devices, 3 special medical foods, and 10 health supplements. Over 200,000 patients have been among the first to access internationally leading pharmaceuticals and medical devices through Lecheng’s licensing policies. From “crossing oceans” to “zero-delay” access, Lecheng has become an important fulcrum for “linking global drugs and serving the health of Chinese people.”
Experts noted that Lecheng’s “pilot first” institutional space, the Hainan Free Trade Port’s policy dividends, and the accelerating convergence of top global medical resources, these “three advantages” stacked together, provide the most suitable soil for the super AI hospital’s launch.
A Continuously Evolving Smart Healthcare System
The super AI hospital uses a self-developed Smart Consortium MaaS Platform (智联体MaaS平台) as its technical foundation, integrating three major engines: a frontier medical knowledge graph, evidence-based medicine databases, and real-world data. It links multiple international alliances spanning hospitals, doctors, technology, devices, pharmaceuticals, payments, and medical tourism to build a cross-institutional, cross-regional, and cross-border medical resource network.
The super AI hospital is organized around six dimensions: knowledge, technology, infrastructure, scenarios, standards, and ecosystem. It operates through a dual-core model of an “online AI Hospital Smart Consortium Platform Promotion Center + offline AI Medical Innovation Drug and Device Experience Exhibition Hall,” creating a smart healthcare service system that deeply integrates online and offline services for patients.
Experts explained that this architectural design is highly consistent with the core principles established in the International AI Hospital Smart Consortium Consensus: restructuring the service architecture through service twinning, expanding service boundaries through virtual-real symbiosis, and reshaping service philosophy through proactive health. The super AI hospital is the first practical implementation of this philosophy: offline, it relies on Lecheng’s physical medical and licensed pharmaceutical resources to provide specialist depth; online, it uses the AI Smart Consortium platform to achieve all-domain reach and continuous care. The two deeply coexist and co-evolve, building an entirely new smart health ecosystem.
The endgame of AI in healthcare is not about “replacing” but about “enabling.” Smart healthcare is about connecting and distributing quality medical resources downward, so that a network of excellent medical resources can benefit more patients.
(Images provided by the event organizers.)
Footnotes:
[1]: The MaaS (Model as a Service) platform is a cloud-based architecture that deploys AI models as accessible services, allowing healthcare institutions to integrate advanced AI capabilities without building their own computational infrastructure.
[2]: “Service twinning (服务孪生)” refers to the concept of creating a digital mirror of physical healthcare services, where AI systems simulate, optimize, and extend real-world medical processes in real time.